QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs
SINGAPORE, July 23, 2024 /PRNewswire/ -- QDX, a computational drug discovery company, today announced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology company, targeting undisclosed, previously undrugged oncology targets.
QDX integrates its world-leading quantum mechanical simulation technology, supercomputing,...
Read more: QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs




